Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,643,729
+$347,470 QoQ
Shares Held
10,506
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,741
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $17,102,053 across 16 Drug Manufacturers - General names. ABBV ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,534 | $7,754,719 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
10,506 | $2,643,729 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,599 | $2,389,971 | |
| 4 | LLY |
ELI LILLY & Co
|
901 | $1,080,686 | |
| 5 | PFE |
Pfizer Inc
|
40,840 | $983,427 | |
| 6 | NVS |
Novartis AG
|
4,893 | $766,830 | |
| 7 | AZN |
Astrazeneca PLC
|
2,497 | $473,481 | |
| 8 | AMGN |
Amgen Inc
|
1,004 | $363,568 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,643,729 | 10,506 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,296,259 | 10,558 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,462,665 | 10,778 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,383,472 | 10,294 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,858,984 | 10,015 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $2,074,457 | 9,901 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,807,742 | 10,173 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,010,741 | 10,182 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $260,881 | 1,521 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $303,560 | 1,667 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $278,791 | 1,799 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $255,190 | 1,712 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $194,415 | 1,443 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $244,314 | 1,533 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $302,210 | 1,870 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $260,233 | 1,939 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $306,932 | 2,004 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $293,905 | 1,813 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $216,233 | 1,597 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $138,720 | 1,286 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $101,376 | 900 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $96,748 | 894 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $143,366 | 1,338 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $79,882 | 912 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $89,441 | 911 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $69,713 | 915 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||